Platet, Nadine <br/><br/>
The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton.  [electronic resource] 

 -  Cancer letters  02 2017 
 - 57-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2016.10.040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actin Cytoskeleton--metabolism<br/>Adherens Junctions--metabolism<br/>Animals<br/>Biomechanical Phenomena<br/>CDX2 Transcription Factor--genetics<br/>Cell Movement<br/>Colonic Neoplasms--genetics<br/>Fluorescent Antibody Technique<br/>Genes, APC<br/>Genetic Predisposition to Disease<br/>HT29 Cells<br/>Humans<br/>Mice, Transgenic<br/>Microscopy, Atomic Force<br/>Neoplasm Metastasis<br/>Phenotype<br/>Proto-Oncogene Proteins c-vav--genetics<br/>RNA Interference<br/>Signal Transduction<br/>Transfection<br/>Tumor Suppressor Proteins--genetics<br/>rho GTP-Binding Proteins--genetics